Placebo to Fosfomycin

DRUG3 trials

Sponsors

Goethe University Frankfurt, University Medical Center Goettingen

Conditions

Recurrent urinary tract infections (rUTI)Urinary Tract Infections

Phase 2

Fecal microbiota transfer for the secondary prevention of recurrent urinary tract infections in premenopausal women: a phase II trial (FEMITRANS)

Not yet recruitingCTIS2025-520452-28-00

Goethe University FrankfurtRecurrent urinary tract infections (rUTI)

Target: 24Updated: 2026-01-07

Phase 4

Reducing Antibiotic Use for Uncomplicated Urinary Tract Infection in General Practice by Treatment With Uva Ursi (UU)- a Comparative Effectiveness Trial

CompletedNCT03151603

University Medical Center GoettingenUrinary Tract Infections

Start: 2017-05-03End: 2019-06-20Updated: 2019-11-27

Unknown Phase

Observational Follow-up Study of REGATTA

CompletedNCT03176563

University Medical Center GoettingenUrinary Tract Infections

Start: 2017-05-03End: 2019-08-20Updated: 2019-11-27

Related Papers

Herbal treatment with uva ursi extract versus fosfomycin in women with uncomplicated urinary tract infection in primary care: a randomized controlled trial.

2021-06-0718 citations

Reducing antibiotic use for uncomplicated urinary tract infection in general practice by treatment with uva-ursi (REGATTA) - a double-blind, randomized, controlled comparative effectiveness trial.

2018-07-0318 citations